Walgreens Boots Alliance, Inc. (WBA) Shares Sold by BRYN MAWR TRUST Co

BRYN MAWR TRUST Co lessened its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 0.3% in the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 221,948 shares of the pharmacy operator’s stock after selling 754 shares during the period. Walgreens Boots Alliance comprises about 1.0% of BRYN MAWR TRUST Co’s holdings, making the stock its 23rd biggest position. BRYN MAWR TRUST Co’s holdings in Walgreens Boots Alliance were worth $17,381,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently bought and sold shares of WBA. Acrospire Investment Management LLC increased its stake in shares of Walgreens Boots Alliance by 3,470.8% in the second quarter. Acrospire Investment Management LLC now owns 2,571 shares of the pharmacy operator’s stock worth $201,000 after purchasing an additional 2,499 shares in the last quarter. Howard Hughes Medical Institute increased its stake in shares of Walgreens Boots Alliance by 20.6% in the second quarter. Howard Hughes Medical Institute now owns 43,854 shares of the pharmacy operator’s stock worth $3,434,000 after purchasing an additional 7,495 shares in the last quarter. ProShare Advisors LLC increased its stake in shares of Walgreens Boots Alliance by 6.7% in the second quarter. ProShare Advisors LLC now owns 1,085,320 shares of the pharmacy operator’s stock worth $84,991,000 after purchasing an additional 68,583 shares in the last quarter. Profund Advisors LLC increased its stake in shares of Walgreens Boots Alliance by 6.7% in the second quarter. Profund Advisors LLC now owns 85,351 shares of the pharmacy operator’s stock worth $6,684,000 after purchasing an additional 5,389 shares in the last quarter. Finally, Choate Investment Advisors increased its stake in shares of Walgreens Boots Alliance by 0.7% in the second quarter. Choate Investment Advisors now owns 33,372 shares of the pharmacy operator’s stock worth $2,613,000 after purchasing an additional 243 shares in the last quarter. Institutional investors and hedge funds own 63.58% of the company’s stock.

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction on Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total transaction of $184,324.32. Following the transaction, the director now directly owns 16,415 shares of the company’s stock, valued at approximately $1,105,878.55. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director John Anthony Lederer acquired 20,000 shares of Walgreens Boots Alliance stock in a transaction on Thursday, October 26th. The shares were bought at an average cost of $67.00 per share, for a total transaction of $1,340,000.00. Following the completion of the transaction, the director now owns 50,000 shares in the company, valued at approximately $3,350,000. The disclosure for this purchase can be found here. 13.50% of the stock is owned by insiders.

Walgreens Boots Alliance, Inc. (NASDAQ WBA) opened at $70.59 on Wednesday. The company has a quick ratio of 0.59, a current ratio of 1.07 and a debt-to-equity ratio of 0.45. Walgreens Boots Alliance, Inc. has a one year low of $63.82 and a one year high of $88.00. The company has a market cap of $71,041.97, a price-to-earnings ratio of 13.80, a P/E/G ratio of 1.25 and a beta of 1.20.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 EPS for the quarter, topping the consensus estimate of $1.21 by $0.10. Walgreens Boots Alliance had a net margin of 3.45% and a return on equity of 18.36%. The company had revenue of $30.15 billion for the quarter, compared to the consensus estimate of $29.93 billion. During the same period in the previous year, the firm earned $1.07 earnings per share. The firm’s revenue for the quarter was up 5.3% on a year-over-year basis. analysts anticipate that Walgreens Boots Alliance, Inc. will post 5.55 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Monday, November 13th will be paid a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 2.27%. The ex-dividend date is Friday, November 10th. Walgreens Boots Alliance’s payout ratio is 42.33%.

Walgreens Boots Alliance declared that its Board of Directors has initiated a share buyback plan on Wednesday, October 25th that authorizes the company to buyback $1.00 billion in outstanding shares. This buyback authorization authorizes the pharmacy operator to purchase shares of its stock through open market purchases. Shares buyback plans are generally an indication that the company’s management believes its shares are undervalued.

COPYRIGHT VIOLATION NOTICE: “Walgreens Boots Alliance, Inc. (WBA) Shares Sold by BRYN MAWR TRUST Co” was published by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this piece on another publication, it was illegally copied and republished in violation of U.S. and international copyright laws. The original version of this piece can be viewed at https://sportsperspectives.com/2017/11/15/walgreens-boots-alliance-inc-wba-shares-sold-by-bryn-mawr-trust-co.html.

WBA has been the subject of a number of analyst reports. BidaskClub upgraded shares of Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research report on Friday, November 10th. UBS AG restated a “buy” rating and issued a $96.00 price objective (down from $97.00) on shares of Walgreens Boots Alliance in a research report on Wednesday, August 23rd. Royal Bank Of Canada initiated coverage on shares of Walgreens Boots Alliance in a research report on Tuesday, September 19th. They issued an “outperform” rating and a $96.00 price objective for the company. Jefferies Group LLC restated a “buy” rating and issued a $95.00 price objective on shares of Walgreens Boots Alliance in a research report on Monday, October 2nd. Finally, Raymond James Financial, Inc. restated a “market perform” rating on shares of Walgreens Boots Alliance in a research report on Wednesday, September 27th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have given a buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $87.63.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply